International Journal of Clinical Research
International Journal of Clinical Research. 2025; 9: (3) ; 10.12208/j.ijcr.20250155 .
总浏览量: 34
汕头市皮肤性病防治院 广东汕头
*通讯作者: 黄榕榕,单位:汕头市皮肤性病防治院 广东汕头;
目的 分析急慢性荨麻疹患者使用盐酸西替利嗪联合葡萄糖酸钙、维生素C等治疗的临床疗效。方法 纳入2022年6月~2023年6月内收治的急慢性荨麻疹患者76例,按照治疗方式分为对照组(补充葡萄糖酸钙和维生素C治疗)和观察组(加用盐酸西替利嗪治疗)各38例,对比两组临床疗效。结果 干预前两组临床症状积分差异无统计学意义,治疗后观察组患者临床症状积分显著低于对照组,差异均有统计学意义(P<0.05)。且对比两组用药不良反应显示,观察组不良反应显著低于对照组,差异均有统计学意义(P<0.05)。结论 对急慢性荨麻疹患者行盐酸西替利嗪联合葡萄糖酸钙、维生素C治疗能够显著改善患者临床症状,用药安全性较高。
Objective To analyze the clinical efficacy of using cetirizine hydrochloride combined with calcium gluconate, vitamin C, and other treatments in patients with acute and chronic urticaria. Methods 76 patients with acute and chronic urticaria admitted between June 2022 and June 2023 were included and divided into a control group (supplemented with calcium gluconate and vitamin C) and an observation group (treated with cetirizine hydrochloride), with 38 cases in each group, according to the treatment method. The clinical efficacy of the two groups was compared. Results There was no statistically significant difference in clinical symptom scores between the two groups before intervention. After treatment, the clinical symptom scores of the observation group were significantly lower than those of the control group, and the differences were statistically significant (P<0.05). And comparing the adverse reactions of the two groups of medication, the adverse reactions in the observation group were significantly lower than those in the control group, and the differences were statistically significant (P<0.05). Conclusion The combination therapy of cetirizine hydrochloride, calcium gluconate, and vitamin C can significantly improve the clinical symptoms of patients with acute and chronic urticaria, and the medication safety is relatively high.
[1] 陈媛,李思成,徐杨,等. 皮敏消胶囊治疗急性和慢性荨麻疹的物质基础与作用机制研究进展[J]. 国外医药(抗生素分册),2024,45(3):154-161.
[2] 高雨松,彭承悦,赵作涛. 奥马珠单抗对慢性荨麻疹合并过敏性休克患者的应用研究[J]. 中华预防医学杂志,2024, 58(3):325-330.
[3] 赵海纵,刘磊,程磊. 左西替利嗪联合地氯雷他定对慢性荨麻疹患儿临床症状改善、炎性因子水平的影响[J]. 系统医学,2024,9(5):161-164.
[4] 詹煜炜,王友力,吕薇. 当归饮子联合氯雷他定治疗慢性荨麻疹的疗效[J]. 中国现代医生,2024,62(6):84-87.
[5] 秦良卿,马海燕. 咪唑斯汀治疗急慢性荨麻疹并发过敏性鼻炎的可行性分析[J]. 中外医疗,2024,43(3):108-110,119.
[6] 郑敏,沈颖. 荨麻疹药物治疗进展[J]. 皮肤科学通报,2020, 37(5):508-512.
[7] 张红娟. 西替利嗪与复方甘草酸苷在慢性荨麻疹治疗中的价值研究[J]. 中国医药指南,2023,21(7):27-30.
[8] 崔秀平,闫伟,何金红. 加味当归补血汤联合抗组胺药物治疗慢性荨麻疹临床疗效观察及安全性评价[J]. 现代中药研究与实践,2021,35(1):77-81.